DexCom Inc. (NASDAQ: DXCM) stock closed at 114.09 per share at the end of the most recent trading day (a -0.36% change compared to the prior day closing price) with a volume of 1.31M shares and market capitalization of 44.09B. Is a component of S&P 500, NASDAQ 100, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 7000 people. DexCom Inc. CEO is Kevin R. Sayer.

The one-year performance of DexCom Inc. stock is -2.22%, while year-to-date (YTD) performance is 0.75%. DXCM stock has a five-year performance of 563.31%. Its 52-week range is between 66.8925 and 134.765, which gives DXCM stock a 52-week price range ratio of 69.54%

DexCom Inc. currently has a PE ratio of 263.20, a price-to-book (PB) ratio of 24.52, a price-to-sale (PS) ratio of 20.30, a price to cashflow ratio of 72.20, a PEG ratio of 2.32, a ROA of 4.07%, a ROC of 6.08% and a ROE of 10.01%. The company’s profit margin is 11.91%, its EBITDA margin is 15.50%, and its revenue ttm is $2.09 Billion , which makes it $5.42 revenue per share.

Of the last four earnings reports from DexCom Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.15 for the next earnings report. DexCom Inc.’s next earnings report date is 27th Apr 2023.

The consensus rating of Wall Street analysts for DexCom Inc. is Strong Buy (1.33), with a target price of $125, which is +9.56% compared to the current price. The earnings rating for DexCom Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

DexCom Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

DexCom Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 16.39, ATR14 : 3.86, CCI20 : 1.82, Chaikin Money Flow : 0.07, MACD : 0.75, Money Flow Index : 60.53, ROC : 1.20, RSI : 50.58, STOCH (14,3) : 60.40, STOCH RSI : 0.00, UO : 50.66, Williams %R : -39.60), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of DexCom Inc. in the last 12-months were: Barry J. Regan (Sold 6 435 shares of value $1 554 446 ), Chad Patterson (Sold 2 329 shares of value $1 040 392 ), Jake Leach (Sold 18 144 shares of value $2 081 822 ), Jereme M. Sylvain (Sold 5 400 shares of value $726 126 ), Kevin R. Sayer (Sold 140 915 shares of value $15 085 607 ), Matthew Vincent Dolan (Sold 6 460 shares of value $688 218 ), Paul R. Flynn (Sold 11 770 shares of value $1 405 661 ), Sadie Stern (Sold 393 shares of value $43 961 ), Steven R. Pacelli (Sold 4 986 shares of value $670 695 )